Evidence map›Paper›PMID 42900361›Full record

ArticleJournal of gastroenterology2026

Risk factors for non-closure of diverting loop ileostomy after rectal cancer surgery: a multicenter prospective study conducted by the Clinical Study Group of Osaka University, Colorectal Group.

Masaaki Miyo, Mamoru Uemura, Yuki Ozato, Yoshinori Kagawa, Yozo Suzuki, Masaru Sasaki, Yusuke Matsuura, Taishi Hata, Kiminori Yanagisawa, Mitsuyoshi Tei and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Masaaki Miyo *Department of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 540-0008, Japan.
Mamoru UemuraDepartment of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2 E2 Yamadaoka, Suita, Osaka, 565-0871, Japan. muemura@gesurg.med.osaka-u.ac.jp.
Yuki Ozato *Department of Surgery, Toyonaka Municipal Hospital, 4-14-1 Shibahara, Toyonaka, Osaka, 560-8565, Japan.
Yoshinori KagawaDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 540-0008, Japan.
Yozo SuzukiDepartment of Surgery, Toyonaka Municipal Hospital, 4-14-1 Shibahara, Toyonaka, Osaka, 560-8565, Japan.
Masaru SasakiDepartment of Gastroenterological Surgery, Higashiosaka City Medical Center, 3-4-5 Nishiiwata, Higashiosaka, Osaka, 578-8588, Japan.
Yusuke MatsuuraDepartment of Gastroenterological Surgery, Ikeda City Hospital, 3-1-18 Jonan, Ikeda, Osaka, 563-8510, Japan.
Taishi HataDepartment of Gastroenterological Surgery, Osaka General Medical Center, 3-1-56 Bandaihigashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.
Kiminori YanagisawaDepartment of Surgery, Kansai Rosai Hospital, 3-1-69 Inabaso, Amagasaki, Hyogo, 660-8511, Japan.
Mitsuyoshi TeiDepartment of Surgery, Osaka Rosai Hospital, 1179-3 Nagasonecho, Sakai-ku, Sakai, Osaka, 591-8025, Japan.
Yusuke TakahashiDepartment of Surgery, Gastroenterological Surgery, Colorectal Cancer Center, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.
Hideki OsawaDepartment of Surgery, Yao Municipal Hospital, 1-3-1 Ryugecho, Yao, Osaka, 581-0069, Japan.
Genta SawadaDepartment of Surgery, Itami City Hospital, 1-100 Koyaike, Itami, Hyogo, 664-8540, Japan.
Takayuki OginoDepartment of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2 E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Norikatsu MiyoshiDepartment of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2 E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Hirofumi YamamotoDepartment of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2 E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Kohei MurataDepartment of Surgery, Kansai Rosai Hospital, 3-1-69 Inabaso, Amagasaki, Hyogo, 660-8511, Japan.
Yuichiro DokiDepartment of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2 E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Hidetoshi EguchiDepartment of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2 E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Clinical Study Group of The University of Osaka, Colorectal Group (CSGO-CG)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiverting loop ileostomy is commonly used to mitigate the consequences of anastomotic leakage after rectal cancer surgery. However, some patients do not undergo stoma closure, resulting in a permanent stoma that may impair quality of life. This study evaluated the closure rate, reasons for non-closure, and associated preoperative factors using multicenter prospective data.

methodsThis study was a subanalysis of a multicenter prospective study conducted at 24 institutions. Patients with rectal adenocarcinoma who underwent laparoscopic or robotic low anterior resection or intersphincteric resection with planned diverting loop ileostomy between July 2015 and April 2021 were included. Stomas not closed within 1 year were classified as non-closed. Preoperative characteristics were compared between the stoma closure and non-closure groups using univariable analyses.

resultsAmong 320 patients, 298 (93.1%) underwent stoma closure, whereas 22 (6.9%) did not. Reasons for non-closure were postoperative complications (n = 9), cancer recurrence (n = 6), patient preference (n = 5), and death (n = 2). In univariable comparisons, patients with stoma non-closure more frequently had ASA-PS ≥2 (86.4% vs. 63.8%, P = 0.036), stage III-IV disease (68.2% vs. 38.9%, P = 0.012), and serum albumin <3.5 g/dL (31.8% vs. 7.4%, P = 0.002) than those who underwent stoma closure.

conclusionsAlthough most diverting loop ileostomies were successfully closed, 6.9% were not reversed. Patients with stoma non-closure more frequently had ASA-PS ≥2, advanced clinical stage, and low serum albumin levels than those who underwent stoma closure. These findings may be useful for preoperative counseling.

trial registrationUMIN000038150.

Indexed as

Diverting loop ileostomyRectal cancerRisk factorsStoma closureStoma non-closure

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.